Molecular formula: | C45H60N10O14 |
Average mass: | 965.031 |
Monoisotopic mass: | 964.429047 |
ChemSpider ID: | 2343247 |
11 of 11 defined stereocentres
(2S)-2-({[(3S,6S,9S,12S)-12-{[(2S)-4-{[(2R,3R,4R,5S,6R)-3-Acetamido-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]amino}-2-amino-4-oxobutanoyl]amino}-6-benzyl-9-(1H-indol-3-ylmethyl)-5,8,11, 14-tetraoxo-1,4,7,10-tetraazacyclotetradecan-3-yl]carbonyl}amino)-4-methylpentanoic acid
[ACD/IUPAC Name](2S)-2-({[(3S,6S,9S,12S)-12-{[(2S)-4-{[(2R,3R,4R,5S,6R)-3-Acetamido-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]amino}-2-amino-4-oxobutanoyl]amino}-6-benzyl-9-(1H-indol-3-ylmethyl)-5,8,11, 14-tetraoxo-1,4,7,10-tetraazacyclotetradecan-3-yl]carbonyl}amino)-4-methylpentansäure
[German]
[ACD/IUPAC Name]Acide (2S)-2-({[(3S,6S,9S,12S)-12-{[(2S)-4-{[(2R,3R,4R,5S,6R)-3-acétamido-4,5-dihydroxy-6-(hydroxyméthyl)tétrahydro-2H-pyran-2-yl]amino}-2-amino-4-oxobutanoyl]amino}-6-benzyl-9-(1H-indol-3-ylméthyl)-5 ,8,11,14-tétraoxo-1,4,7,10-tétraazacyclotétradécan-3-yl]carbonyl}amino)-4-méthylpentanoïque
[French]
[ACD/IUPAC Name]β-D-Glucopyranosylamine, 2-(acetylamino)-N-[(3S)-3-amino-4-[[(3S,6S,9S,12S)-3-[[[(1S)-1-carboxy-3-methylbutyl]amino]carbonyl]-9-(1H-indol-3-ylmethyl)-5,8,11,14-tetraoxo-6-(phenylmethyl)-1,4,7,10-te traazacyclotetradec-12-yl]amino]-1,4-dioxobutyl]-2-deoxy-
[ACD/Index Name](2S)-2-[[(3S,6S,9S,12S)-12-[[(2S)-4-[[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]amino]-2-amino-4-oxobutanoyl]amino]-9-(1H-indol-3-ylmethyl)-5,8,11,14-tetraoxo-6-(phenylmethyl)1,4,7,10-tetrazacyclotetradecane-3-carbonyl]amino]-4-methylpentanoic acid
183747-35-5
[RN]cyclo(Asn(2-deoxy-2-AcNH-β-D-Glc)-Asp-Trp-Phe-Dap-Leu)cyclo(2β,5β)
Cyclo(N-(2-acetamido-2-deoxy-β-D-glucopyranosyl)-L-asparginyl-L-α-aspartyl-L-tryptophyl-L-phenylalanyl-L-2,3-diaminopropionyl-L-leucyl), cyclic(2-5)-peptide.
MEN-11,420
nepadutant
[INN]